Delivery Order SPE2DB20D2104-SPE2DB25FMWNS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,182.31 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Losartan Potassium 100 mg. This non-set-aside, competitively awarded contract features firm fixed pricing and was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a small-value transaction...
- The Defense Logistics Agency awarded a delivery order valued at $2,509.04 to AmerisourceBergen Drug Corp for the supply of Losartan Potassium 100 mg tablets in quantities of 1,000 units. This non-competitive delivery order carries a firm fixed price arrangement and is scheduled for completion by September 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the same...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Losartan Potassium 100 mg tablets in quantities of 1,000 units, with a ceiling value of $1,663.10. This firm fixed-price delivery order is set to be completed by July 31, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was awarded competitively without set-aside provisions, reflecting AmerisourceBergen's capability to meet...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,414.81 to AmerisourceBergen Drug Corp for the supply of Losartan Potassium 100 mg tablets in quantities of 1,000 units. This award, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award based on open competition. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded a delivery order valued at $3,733.57 to AmerisourceBergen Drug Corp for the supply of Losartan Potassium 100 mg tablets in quantities of 1,000 units. The contract is a firm fixed price delivery order with an ultimate completion date of August 27, 2025, and was awarded on August 26, 2025. No set-aside designation was applied to this award, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,084.59 to AmerisourceBergen Drug Corp for the supply of Losartan Potassium 25 mg tablets in quantities of 1,000 units. This order, which was competitively awarded without a set-aside designation, represents a firm fixed-price delivery under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The product will be delivered to AmerisourceBergen's Conshohocken, Pennsylvania location, with an...
- The Defense Logistics Agency awarded a delivery order valued at $6,956.52 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Losartan Potassium 50 mg, with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of 1,000 tablets of Losartan Potassium 100 mg, valued at $3,470.22. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by September 4, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Losartan potassium is a generic antihypertensive...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,244.73 for 1,000 tablets of Losartan Potassium 100 mg, with an ultimate completion date of May 6, 2025. This non-set-aside, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,350.21 to AmerisourceBergen Drug Corp for the supply of Losartan Potassium 100 mg tablets (1,000 units) with an ultimate completion date of August 27, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMWNSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,276.16 to AmerisourceBergen Drug Corp for 1,000 tablets of Losartan Potassium 100 mg, a commonly prescribed antihypertensive medication. The contract, executed on July 28, 2025, with an ultimate completion date of July 29, 2025, utilizes firm fixed-price terms and requires performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award includes no set-aside designation and was competitively awarded through an open procurement process. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply pharmaceutical products and medical supplies to military healthcare systems worldwide, including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen demonstrates substantial capability in fulfilling diverse medical supply requirements across multiple therapeutic domains through its extensive contract portfolio with the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/28/25 |